Posters
Presenting Author Academic/Professional Position
Medical Student
Academic Level (Author 1)
Medical Student
Academic Level (Author 2)
Medical Student
Academic Level (Author 3)
Faculty
Presentation Type
Poster
Discipline Track
Clinical Science
Abstract Type
Research/Clinical
Abstract
Background: Psoriatic arthritis is an aggressive condition that may be characterized by compromised quality of life and significant morbidity. The prevalence of psoriatic arthritis in patients with psoriasis is around 1.7% at 5 years, 3.1% at 10 years, 5.1% at 20 years, and 20.5% at 30 years which shows an increase in joint involvement with increasing age, at least until the age of 30. The objective of this study was to explore joint involvement in psoriatic patients in this region and determine what are the demographic disparities in Psoriatic patients regarding joint involvement. We hypothesized that individuals with psoriasis between 40-50 years of age would have increased frequency of joint involvement.
Methods: This was a retrospective chart review, from January 1, 2018 to September 4, 2024, and data was gathered from the University of Texas Rio Grande Valley (UTRGV) UTHealth electronic database. Various demographics were collected for both psoriatic arthritis and psoriasis only individuals using ICD-10 diagnosis codes L40.0-L40.4, L40.8 for psoriasis only, and L40.5 for psoriatic arthritis. Various statistical analyses were performed, such as univariate analysis, chi-squared test, multivariate analysis, and binary logistic regression analysis.
Results: After adjusting for the other variables in the study, there were no statistically significant results (p-value) indicating no significant effect of age at diagnosis (0.1125), sex (0.2551), being underweight (0.1079), ethnicity (0.9901), county of residence (Cameron=0.2525, Hidalgo=0.2577), or marital status (married=0.3292, other=0.9048) on joint involvement in individuals with psoriasis. However, individuals classified as obese (0.0175) or overweight (0.0114) had significantly higher odds of joint involvement.
Conclusion: Our results suggest that along with treating psoriasis patients accordingly, with the standard of care, extra caution should be taken when caring for psoriatic individuals who are overweight or obese, particularly in the RGV and possibly other populations similar to it, due to the increased risk of joint involvement in these individuals.
Recommended Citation
Martin, Blake C.; Hensley, Jared; and Peiris, Manoj, "Joint Involvement in a Psoriasis Affected Population in a Medically Underrepresented Region" (2025). Research Symposium. 43.
https://scholarworks.utrgv.edu/somrs/2025/posters/43
Included in
Joint Involvement in a Psoriasis Affected Population in a Medically Underrepresented Region
Background: Psoriatic arthritis is an aggressive condition that may be characterized by compromised quality of life and significant morbidity. The prevalence of psoriatic arthritis in patients with psoriasis is around 1.7% at 5 years, 3.1% at 10 years, 5.1% at 20 years, and 20.5% at 30 years which shows an increase in joint involvement with increasing age, at least until the age of 30. The objective of this study was to explore joint involvement in psoriatic patients in this region and determine what are the demographic disparities in Psoriatic patients regarding joint involvement. We hypothesized that individuals with psoriasis between 40-50 years of age would have increased frequency of joint involvement.
Methods: This was a retrospective chart review, from January 1, 2018 to September 4, 2024, and data was gathered from the University of Texas Rio Grande Valley (UTRGV) UTHealth electronic database. Various demographics were collected for both psoriatic arthritis and psoriasis only individuals using ICD-10 diagnosis codes L40.0-L40.4, L40.8 for psoriasis only, and L40.5 for psoriatic arthritis. Various statistical analyses were performed, such as univariate analysis, chi-squared test, multivariate analysis, and binary logistic regression analysis.
Results: After adjusting for the other variables in the study, there were no statistically significant results (p-value) indicating no significant effect of age at diagnosis (0.1125), sex (0.2551), being underweight (0.1079), ethnicity (0.9901), county of residence (Cameron=0.2525, Hidalgo=0.2577), or marital status (married=0.3292, other=0.9048) on joint involvement in individuals with psoriasis. However, individuals classified as obese (0.0175) or overweight (0.0114) had significantly higher odds of joint involvement.
Conclusion: Our results suggest that along with treating psoriasis patients accordingly, with the standard of care, extra caution should be taken when caring for psoriatic individuals who are overweight or obese, particularly in the RGV and possibly other populations similar to it, due to the increased risk of joint involvement in these individuals.
